首页 › 基金 › Seven Fleet Capital Management LP › STRO

Seven Fleet Capital Management LP 对 STRO 的持仓历史

SUTRO BIOPHARMA INC · 医疗保健

Seven Fleet Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 STRO(SUTRO BIOPHARMA INC)99,894 股,市值约 US$1.6M,约占其申报组合的 0.31%,在其申报持仓中市值排名第 38 位。 Seven Fleet Capital Management LP 最近 2 个申报季度中有 2 个季度披露了 STRO 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)99.89K 股
申报持仓市值$1.61M
组合权重0.31%
首次申报Q2 2026
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Seven Fleet Capital Management LP 对 STRO 的持仓演变

Seven Fleet Capital Management LP 于 Q2 2026 首次披露 STRO 持仓:159,118 股(约 US$3.8M)。 在 2 次申报中,Seven Fleet Capital Management LP 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 99,894 股、市值约 US$1.6M,环比减持 -59,224 股。。 持仓曾出现大幅变动:Q3 2026 减持约 37% (随后一个季度股价下跌 42%)。

逐季持仓明细

季度股数金额变化
Q2 2026 159.12K $3.79M 新进
Q3 2026 99.89K $1.61M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 STRO 与 13F 数据

STRO(SUTRO BIOPHARMA INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 STRO,申报仓位最大的包括:BVF INC/IL (US$20.2M), Affinity Asset Advisors, LLC (US$18.6M), Samsara BioCapital, LLC (US$17.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 STRO 的基金

查看 STRO 的全部基金持有人 →

常见问题

How long has Seven Fleet Capital Management LP held STRO?

Seven Fleet Capital Management LP has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Seven Fleet Capital Management LP's current position in STRO?

As of Q3 2026, Seven Fleet Capital Management LP holds 99.89K shares of STRO (SUTRO BIOPHARMA INC), valued at $1.61M, representing 0.31% of its reported portfolio and ranking #38.

Has Seven Fleet Capital Management LP been buying or selling STRO?

In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP reduced its position in STRO.

Which other funds hold STRO?

Other major institutional holders of STRO include BVF INC/IL, Affinity Asset Advisors, LLC, Samsara BioCapital, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.